Tajer, Carlos; Ceresetto, José; Bottaro, Federico; Martí, Alejandra; Casey, Marcelo; TERRA Trial investigators
(SAGE, 2016)
Background: Oral anticoagulation therapy with vitamin K antagonists (VKA) such as warfarin and acenocoumarol is recommended in patients with atrial fibrillation (AF) and risk factors for embolism. The quality of anticoagulation ...
